The CLINICAL TRIAL Company (Canada) Limited (TCTC) was incorporated 2006. TCTC realised there was an opportunity in the CRO sector for a company which targeted medium size clinical trials and novel products which lacked a classical road map to the market. Large CROs prioritise studies from the big pharmaceutical companies, for good business reasons. However, this approach sometimes disadvantages their SME clients who are equally keen to complete their clinical trials quickly. TCTC are experts in advanced therapies, such as cell and gene therapies, as well as Orphan drug and biologics. TCTC successfully executed clinical trials for the first Gene therapy to be approved in the Western world. This approval trailblazed the way for other gene therapies in development and strengthens TCTCs reputation as a leader in the field of Advanced Therapy Clinical trials. The CLINICAL TRIAL Company staff are largely people from successful biotechs who understand how to bring novel products to market. Where possible, traditional one size fits all lengthy approval routes are replaced with pragmatic real-life planning without risk to long term success. Its Directors and experienced management team offer comprehensive client-side experience to you the customer. This offering appeals to people unhappy with delays caused by conventional off-the-shelf approval strategies which ignore the unique nature of each product and market. The company enjoys an open and enthusiastic culture which results in maximum personal motivation. Staff are flexible and embrace new challenges. Continuous cross-fertilisation across disciplines is encouraged, resulting in high levels of personal job satisfaction. The Company operates an ISO 9001:2008 Quality Management System and is Headquartered near Montreal Airport in Quebec, Canada .